These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3904331)

  • 21. Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein.
    Dacquet C; Mironneau C; Mironneau J
    Br J Pharmacol; 1987 Sep; 92(1):203-11. PubMed ID: 2959345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental studies of the effect of diltiazem (Ca-antagonist) on cerebral circulation and cerebral arterial spasm].
    Kyoi K; Yokoyama K; Tsukamoto M; Morimoto T; Sakaki T; Kinugawa K; Okazaki A; Utsumi S
    No To Shinkei; 1982 Dec; 34(12):1145-51. PubMed ID: 7159544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium antagonists for uterine relaxation.
    Lechner W; Marth C; Keene F
    Gynecol Obstet Invest; 1989; 28(3):144-6. PubMed ID: 2807036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 25. Actions of diltiazem on single smooth muscle cells and on neuromuscular transmission in the vascular bed.
    Kuriyama H; Ito Y; Suzuki H; Kitamura K; Itoh T; Kajiwara M; Fujiwara S
    Circ Res; 1983 Feb; 52(2 Pt 2):I92-6. PubMed ID: 6299608
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diltiazem: a new calcium antagonist in the Netherlands].
    Robbens EJ; Hagemeijer F
    Ned Tijdschr Geneeskd; 1986 Mar; 130(12):535-7. PubMed ID: 3960166
    [No Abstract]   [Full Text] [Related]  

  • 27. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium-channel blocking agents for gastrointestinal disorders.
    Castell DO
    Am J Cardiol; 1985 Jan; 55(3):210B-213B. PubMed ID: 3881916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
    Day RW
    Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic application of calcium-channel antagonists for pulmonary hypertension.
    Packer M
    Am J Cardiol; 1985 Jan; 55(3):196B-201B. PubMed ID: 3881914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promising uses of calcium-channel blocking agents.
    Bussey HI; Talbert RL
    Pharmacotherapy; 1984; 4(3):137-43. PubMed ID: 6377247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein.
    Marriott JF
    Br J Pharmacol; 1988 Sep; 95(1):145-54. PubMed ID: 3219471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.
    Cavero I; Shepperson N; Lefèvre-Borg F; Langer SZ
    Circ Res; 1983 Feb; 52(2 Pt 2):I69-76. PubMed ID: 6131754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism of inhibitory action of diltiazem on vascular smooth muscle contractility.
    van Breemen C; Hwang O; Meisheri KD
    J Pharmacol Exp Ther; 1981 Aug; 218(2):459-63. PubMed ID: 7252845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of calcium-channel blockers in obstructive airway disease.
    Ahmed T; Abraham WM
    Chest; 1985 Aug; 88(2 Suppl):142S-151S. PubMed ID: 2410203
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mechanism of action of calcium-antagonists on the smooth vascular muscles].
    Ferrari R; Cargnoni A; Rodella A; Ciampalini G; Raddino R
    Cardiologia; 1985 May; 30(5):347-56. PubMed ID: 2421900
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of calcium antagonist (diltiazem) on symptomatic cerebral vasospasm].
    Takagi T; Kuwahara M; Nagai H; Hotta K; Ozawa M; Nagatomi H
    Neurol Med Chir (Tokyo); 1986 Nov; 26(11):863-9. PubMed ID: 2437477
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcium channel blockers in emergency medicine.
    Young GP
    Ann Emerg Med; 1984 Sep; 13(9 Pt 1):712-22. PubMed ID: 6380352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effect of diltiazem on myocardial cell injury during the calcium paradox.
    Ashraf M; Onda M; Hirohata Y; Schwartz A
    J Mol Cell Cardiol; 1982 Jun; 14(6):323-7. PubMed ID: 7131565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.